GAP43 and Alzheimer disease: The role of GAP-43 in synaptic plasticity and neurodegeneration has been further validated by post-mortem studies, showing reduced expression in the frontal cortex and hippocampus of patients with AD, with a negative correlation with senile plaque density [46].